Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)
Rethinking Clinical Trials
NOVEMBER 1, 2022
Russell Rothman, MD, MPP. Emily O’Brien, PhD, FAHA. Associate Professor. Duke Clinical Research Institute. Duke University School of Medicine. Department of Population Health Sciences. Senior Vice President, Population and Public Health. Director, Vanderbilt Institute for Medicine and Public Health. Vanderbilt University Medical Center.
Let's personalize your content